Systemic inflammatory response syndrome after cardiac operations

Annals of Thoracic Surgery

Volumn 61, Issue 6, 1996, Pages 1714-1720

  Cremer, Joachim ^a,b   Martin, Marius ^a   Redl, Heinz ^a   Bahrami, Soheyl ^a   Abraham, Conny ^a   Graeter, Thomas ^a   Haverich, Axel ^a   Schlag, Günter ^a   Borst, Hans Georg ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIBIOTIC AGENT; CEFAZOLIN; CEFOTAXIME; DOPAMINE; ELASTASE; FLUCLOXACILLIN; INOTROPIC AGENT; INTERLEUKIN 6; INTERLEUKIN 8; NORADRENALIN; TOBRAMYCIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; HEART SURGERY; HEMODYNAMICS; HUMAN; INFLAMMATION; MEDIATOR RELEASE; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL;

EID: 0030012509     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(96)00055-0     Document Type: Article

References (20)

1. Kirklin JK, Westaby S, Blackstone EH, et al. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983;86:845-57.
2. Van Oeveren W, Kazatchkine MD, Descamps-Latscha B, et al. Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation. J Thorac Cardiovasc Surg 1985;89:888-99.
3. Tennenberg SD, Clardy CW, Bailey WW, et al. Complement activation and lung permeability during cardiopulmonary bypass. Ann Thorac Surg 1990;50:597-601.
4. Butler J, Chong GL, Baigrie RJ, et al. Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation. Ann Thorac Surg 1992;53:833-8.
5. Riegel W, Spillner G, Schlosser V, et al. Plasma levels of main granulocyte components during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1988;95:1014-9.
6. Baue AE. The role of the gut in the development of multiple organ dysfunction in cardiothoracic patients. Ann Thorac Surg 1993;55:822-9.
7. Rocke DA, Gaffin SL, Wells MT, et al. Endotoxemia associated with cardio-pulmonary bypass. J Thorac Cardiovasc Surg 1987;93:832-7.
8. Bidstrup BP, Royston D, Sapsford RN, Taylor KM. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg 1989;97:364-72.
9. Schlag G, Redl H, Davies J, Haller I. Anti-tumor necrosis factor antibody treatment of recurrent bacteremia in a baboon model. Shock 1994;2:10-8.
10. Redl H, Schlag G, Bahrami S, Schade U, Ceska M, Stütz P. Plasma neutrophil-activating peptide-1/interleukin-8 and neutrophil elastase in a primate bacteremia model. J Infect Dis 1991;164:383-8.
11. Engelberts I, Möller A, Schoen GJM, et al. Evaluation of measurement of human TNF in plasma by ELISA. Lymphokine Cytokine Res 1991;10:69-76.
12. Redl H, Schlag G, Adolf GR, Natmessnig B, Davies J. Tumor necrosis factor (TNF)-dependent shedding of the p55 TNF receptor in a baboon model of bacteremia. Infect Immun 1995;1:297-300.
13. Redl H, Bahrami S, Schlag G, Traber DL. Clinical detection of LPS and animal models of endotoxemia. Immunobiology 1993;187:330-45.
14. Andersen LW, Baek L, Degn H, et al. Presence of circulating endotoxins during cardiac operations. J Thorac Cardiovasc Surg 1987;93:115-9.
15. Redl H, Schlag G, Bahrami S, et al. The cytokine network in trauma and sepsis. I: TNF and IL-8. In: Schlag G, ed. Pathophysiology of shock, sepsis, and organ failure. Berlin: Springer, 1993:468-90.
16. Adolf GR, Apfler I. Monoclonal antibodies to soluble human TNF receptors (TNF binding protein) enhance its ability to block TNF toxicity. Cytokine 1992;4:180-4.
17. Lantz M, Malik M, Slevin ML, Olsson I. Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans. Cytokine 1990;2:402-6.
18. Tanio JW, Basu ChB, Albelda St, Eisen HJ. Differential expression of the cell adhesion molecules ICAM-1, VCAM-1, and E-selectin in normal and posttransplantation myocardium. Cell adhesion molecule expression in human cardiac allografts. Circulation 1994;89:1760-8.
19. Pacher R, Redl H, Frass M, et al. Relationship between neopterin and granulocyte elastase plasma levels and the severity of multiple organ failure. Crit Care Med 1989;17: 221-6.
20. Jansen NJG, van Oeveren W, v.d. Broek L, et al. Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991;102:515-25.